Therapix – Bridging development and financial gap for biopharmaceutical companies
Therapix Biosciences, a biopharmaceutical Israeli-based company, identifying and accelerating the development of specialty biopharmaceuticals with attractive risk/return profiles.
Therapix offers it’s investors an improved risk-reward profile
Therapix is targeted at significant value creation via hands-on leadership to our portfolio companies. Therapix provide growth capital, management, advice, guidance and networking to our partners. Our expertise and leadership will help accelerate growth, build long-term value and enable business transformation for each of our portfolio companies.
JUDGMENT
Therapix identify and select exceptional technologies based on our vast knowledge and expertise in various biopharma aspects according to stringent criteria.
DIVERSIFICATION
Aim to reduce risk by allocating investments among various assets and technologies, and to maximize return by investing in different areas.
NOVEL TECHNOLOGIES
A point of access to promising Israeli ventures, leverage the local entrepreneurial ecosystem and connect it with international strategic partners.
PUBLIC
Leverage the Publicly-traded entity in raising capital & awareness, to be a patient & transparent partner, and nurture our portfolio partnering, M&A or IPO.